Mate do you read? In that AFR document it says it may be delayed but most likely not. Read it again he didn't announce anything except confusion. Enough said mate. You were on the ban wagan months ago but sold your shares for a profit and now praying to go back to a dollar. Yeh it's valued at 0.98 cents lol. Market cap of 500 million for a stock growing in profit of 800 percent this year and is looking at doubling growth in 2017 and 18. Yeh mate were not talking about Myer which has been on the stock market the last 10 years with 2-4 percent growth per annum lol. Mate I don't think you know how to value growth stocks. Bellamy should be at 5 dollars damn everyone sell its market cap is 1.02 billion.
I know the Chinese market more than you can imagine. One day you will find out who I am but when you know that A2 is selling as the number 1 baby formula in major retailers, number 4 baby formula world wide on Tmall, number 1 Australian selling formula on Tmall, JD and Kaola.com and on top of that UK is now profitable and USA distribution is getting larger by the day then you know what's coming and people like you don't phase me. On top of that getting feedback from someone you don't need to know UK and USA is seeing great progress and people are accepting the milk then again you don't phase me. And one more thing when evidence comes out in 1 study confirming the A2 milk and Monash university coming soon as well as the study in 600 infant children in China well it doesn't phase me. Let me keep going for you which doesn't phase me. Synlait second plant announced this month, the Chinese pharmacist coming down this month for the number 1 selling baby formula well it doesn't phase me again
Everyone that bought today Congrates because there are people out there about to get burnt .
- Forums
- ASX - By Stock
- A2M
- TA price target 1.06 A2M
A2M
the a2 milk company limited
Add to My Watchlist
1.67%
!
$7.93

TA price target 1.06 A2M, page-822
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$7.93 |
Change
0.130(1.67%) |
Mkt cap ! $5.741B |
Open | High | Low | Value | Volume |
$7.87 | $7.99 | $7.71 | $17.74M | 2.261M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 111 | $7.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.96 | 3799 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 7.710 |
4 | 5739 | 7.700 |
1 | 64 | 7.680 |
3 | 2750 | 7.670 |
1 | 500 | 7.660 |
Price($) | Vol. | No. |
---|---|---|
7.960 | 565 | 1 |
7.990 | 8000 | 1 |
8.000 | 6318 | 7 |
8.010 | 6039 | 2 |
8.020 | 3294 | 2 |
Last trade - 16.13pm 27/06/2025 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online